Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk

Cell Communication and Signaling

Volumn 10, Issue , 2012, Pages

  Özel, Cem ^a   Seidel, Jeanette ^a   Meyer Staeckling, Sönke ^b   Brandt, Burkhard H ^c   Niggemann, Bernd ^a   Zänker, Kurt S ^a   Dittmar, Thomas ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C BETA; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ARTICLE; BREAST CANCER; BREAST EPITHELIAL CELL; CANCER CELL; CANCER CELL CULTURE; CELL CLONE; CELL MIGRATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYBRID CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84860821830     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-10-10     Document Type: Article

References (63)

1. Dittmar T, Zänker KS, Cell Fusion in Health and Disease Dordrecht, The Netherlands: Springer 2011
2. Hybridization of transformed cells with lymphocytes as 1 of the probable causes of the progression leading to the development of metastatic malignant cells. Mekler LB, Vestn Akad Med Nauk SSSR 1971 26 80 89 5580967
3. Transformation of a normal differentiated cell of an adult organism, induced by the fusion of this cell with another normal cell of the same organism but with different organ or tissue specificity. Mekler LB, Drize OB, Osechinskii IV, Shliankevich MA, Vestn Akad Med Nauk SSSR 1971 26 75 80 5172986
4. ber Zellverschmelzung mit quantitativ abnormer Chromosomenverteilung als Ursache der Geschwulstbildung. Aichel O, Vorträge und Aufsätze über Entwicklungsmechanik der Organismen Leipzig, Germany: Wilhelm Engelmann, Roux W, 1991 1 115
5. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Lu X, Kang Y, Proc Natl Acad Sci USA 2009 106 9385 9390 10.1073/pnas.0900108106 19458257
6. Cell fusion: a hidden enemy? Duelli D, Lazebnik Y, Cancer Cell 2003 3 445 448 10.1016/S1535-6108(03)00114-4 12781362 (Pubitemid 38340291)
7. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, Meyer-Staeckling S, Brandt BH, Niggemann B, Zanker KS, Clin Exp Metastasis 2011 28 75 90 10.1007/s10585-010-9359-3 20981475
8. Co-cultivation of murine BMDCs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant hybrid cells. Nagler C, Hardt C, Zänker KS, Dittmar T, Canc Cell Int 2011 11 21 10.1186/1475-2867-11-21
9. Opinion: the origin of the cancer stem cell: current controversies and new insights. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ, Nat Rev Cancer 2005 5 899 904 10.1038/nrc1740 16327766 (Pubitemid 41746034)
10. Recurrence cancer stem cells-made by cell fusion? Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, Zanker KS, Med Hypotheses 2009 73 542 547 10.1016/j.mehy.2009.05.044 19564079
11. Cell fusion as a hidden force in tumor progression. Lu X, Kang Y, Cancer Res 2009 69 8536 8539 10.1158/0008-5472.CAN-09-2159 19887616
12. Cell Fusion, Drug Resistance and Recurrence CSCs. Nagler C, Zanker KS, Dittmar T, Adv Exp Med Biol 2011 714 173 182 21506014
13. Carcinogenesis driven by bone marrow-derived stem cells. Dittmar T, Seidel J, Zänker KS, Niggemann B, Contrib Microbiol 2006 13 156 169 16627964
14. Tumour cell hybridization and metastasis revisited. Pawelek JM, Melanoma Res 2000 10 507 514 10.1097/00008390-200012000-00001 11198471 (Pubitemid 32011972)
15. Molecular and cellular mechanisms of Mammalian cell fusion. Zhou X, Platt JL, Adv Exp Med Biol 2011 713 33 64 10.1007/978-94-007-0763-4-4 21432013
16. Macrophage fusion: the making of osteoclasts and giant cells. Vignery A, J Exp Med 2005 202 337 340 10.1084/jem.20051123 16061722 (Pubitemid 41126949)
17. CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts. Cui W, Cuartas E, Ke J, Zhang Q, Einarsson HB, Sedgwick JD, Li J, Vignery A, Proc Natl Acad Sci USA 2007 104 14436 14441 10.1073/pnas.0702811104 17726108 (Pubitemid 350003279)
18. Syncytin is involved in breast cancer-endothelial cell fusions. Bjerregaard B, Holck S, Christensen IJ, Larsson LI, Cell Mol Life Sci 2006 63 1906 1911 10.1007/s00018-006-6201-9 16871371
19. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. Strick R, Ackermann S, Langbein M, Swiatek J, Schubert SW, Hashemolhosseini S, Koscheck T, Fasching PA, Schild RL, Beckmann MW, Strissel PL, J Mol Med 2007 85 23 38 17066266 (Pubitemid 46020940)
20. Prognostic role of syncytin expression in breast cancer. Larsson LI, Holck S, Christensen IJ, Hum Pathol 2007 38 726 731 10.1016/j.humpath.2006.10. 018 17306327 (Pubitemid 46578241)
21. Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. Fang TC, Alison MR, Cook HT, Jeffery R, Wright NA, Poulsom R, J Am Soc Nephrol 2005 16 1723 1732 10.1681/ASN.2004121089 15814835 (Pubitemid 41716478)
22. Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY, Steinman L, Rossi FM, Blau HM, Nat Cell Biol 2008 10 575 583 10.1038/ncb1720 18425116 (Pubitemid 351627377)
23. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nygren JM, Liuba K, Breitbach M, Stott S, Thoren L, Roell W, Geisen C, Sasse P, Kirik D, Bjorklund A, et al. Nat Cell Biol 2008 10 584 592 10.1038/ncb1721 18425115 (Pubitemid 351627378)
24. Inflammation and cancer: back to Virchow? Balkwill F, Mantovani A, Lancet 2001 357 539 545 10.1016/S0140-6736(00)04046-0 11229684 (Pubitemid 32173595)
25. Inflammation and cancer. Coussens LM, Werb Z, Nature 2002 420 860 867 10.1038/nature01322 12490959 (Pubitemid 36019639)
26. Editorial. Virchow R, Virchows Arch Pathol Anat Physiol Klin Med 1855 3 23
27. A spontaneous murine melanoma lung metastasis comprised of host × tumor hybrids. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM, Cancer Res 2000 60 2512 2519 10811133 (Pubitemid 30262446)
28. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, Wong MH, Cancer Res 2011 71 1497 1505 10.1158/0008-5472.CAN-10-3223 21303980
29. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH, Proc Natl Acad Sci USA 2006 103 6321 6325 10.1073/pnas.0508593103 16606845
30. Sousa de Freitas J, Espreafico EM, Pawelek JM: Human monocyte × mouse melanoma fusion hybrids express human gene. Chakraborty AK, Gene 2001 275 103 106 10.1016/S0378-1119(01)00647-3 11574157 (Pubitemid 32907331)
31. Melanoma × macrophage hybrids with enhanced metastatic potential. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D, Pawelek J, Clin Exp Metastasis 1998 16 299 312 9626809 (Pubitemid 28255525)
32. Breast stem cells spontaneously fuse with breast cancer cells: Impacts on Cancer Stem Cell formation? Schwitalla S, Seidel J, Keil S, Trosko JE, Chang CC, Meyer-Staeckling S, Brandt BH, Niggemann B, Zänker KS, Dittmar T, Proc Amer Assoc Cancer Res 2008 49 #5007
33. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Kollet O, Petit I, Kahn J, Samira S, Dar A, Peled A, Deutsch V, Gunetti M, Piacibello W, Nagler A, Lapidot T, Blood 2002 100 2778 2786 10.1182/blood-2002-02-0564 12351385
34. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. Dittmar T, Husemann A, Schewe Y, Nofer JR, Niggemann B, Zanker KS, Brandt BH, FASEB J 2002 16 1823 1825 12354693
35. The stromal cell-derived factor-1alpha dependent migration of human cord blood CD34 haematopoietic stem and progenitor cells switches from protein kinase C (PKC)-alpha dependence to PKC-alpha independence upon prolonged culture in the presence of Flt3-ligand and interleukin-6. Kasenda B, Kassmer SH, Niggemann B, Schiermeier S, Hatzmann W, Zanker KS, Dittmar T, Br J Haematol 2008 142 831 835 10.1111/j.1365-2141.2008.07256.x 18540940
36. Cytokine combinations differentially influence the SDF-1alpha-dependent migratory activity of cultivated murine hematopoietic stem and progenitor cells. Kassmer SH, Niggemann B, PunÖzel M, Mieck C, Zanker KS, Dittmar T, Biol Chem 2008 389 863 872 18627320
37. Regulation of Raf-Akt Cross-talk. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M, J Biol Chem 2002 277 31099 31106 10.1074/jbc.M111974200 12048182 (Pubitemid 34970815)
38. Phosphorylation and regulation of Raf by Akt (protein kinase B). Zimmermann S, Moelling K, Science 1999 286 1741 1744 10.1126/science.286.5445. 1741 10576742 (Pubitemid 129515882)
39. Regulation of Raf-1 by direct feedback phosphorylation. Dougherty MK, Muller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK, Mol Cell 2005 17 215 224 10.1016/j.molcel.2004.11.055 15664191 (Pubitemid 40138617)
40. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, et al. Aging 2011 3 192 222 21422497
41. Integrins and Signal Transduction Pathways: The Road Taken. Clark EA, Brugge JS, Science 1995 268 233 239 10.1126/science.7716514 7716514
42. Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Heyder C, Gloria-Maercker E, Hatzmann W, Niggemann B, Zanker KS, Dittmar T, Clin Exp Metastasis 2005 22 99 106 10.1007/s10585-005-4335-z 16086230 (Pubitemid 41185847)
43. c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. Brandt BH, Roetger A, Dittmar T, Nikolai G, Seeling M, Merschjann A, Nofer JR, Dehmer-Moller G, Junker R, Assmann G, Zaenker KS, FASEB J 1999 13 1939 1949 10544177 (Pubitemid 29517624)
44. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, Schlessinger J, EMBO J 1998 17 414 422 10.1093/emboj/17.2.414 9430633 (Pubitemid 28045482)
45. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF, Hynes NE, Proc Natl Acad Sci USA 2003 100 8933 8938 10.1073/pnas.1537685100 12853564 (Pubitemid 36899201)
46. The ErbB receptors and their role in cancer progression. Holbro T, Civenni G, Hynes NE, Exp Cell Res 2003 284 99 110 10.1016/S0014-4827(02)00099-X 12648469 (Pubitemid 36331969)
47. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-gamma1 signalling in breast cancer cell migration and dissemination. Balz LM, Bartkowiak K, Andreas A, Pantel K, Niggemann B, Zanker KS, Brandt BH, Dittmar T, J Pathol 2012 doi: 10.1002/path.3991
48. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, Reid K, Moelling K, Yancopoulos GD, Glass DJ, Science 1999 286 1738 1741 10.1126/science.286.5445. 1738 10576741 (Pubitemid 129515881)
49. A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy. Lee-Hoeflich ST, Crocker L, Yao E, Pham T, Munroe X, Hoeflich KP, Sliwkowski MX, Stern HM, Cancer Res 2008 68 5878 5887 10.1158/0008-5472. CAN-08-0380 18632642
50. ErbB3 ablation impairs phosphatidylinositol 3-kinase (PI3K)/AKT-dependent mammary tumorigenesis. Muraoka-Cook RS, Garrett J, Sanchez VK, Stanford JC, Young C, Chakrabarty A, Rinehart C, Zhang Y, Wu Y, Greenberger LM, et al. Cancer Res 2011 71 3941 3951 10.1158/0008-5472.CAN-10-3775 21482676
51. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Dittmar T, Heyder C, Gloria-Maercker E, Hatzmann W, Zanker KS, Clin Exp Metastasis 2008 25 11 32 18563596 (Pubitemid 351191223)
52. Involvement of chemokine receptors in organ-specific metastasis. Zlotnik A, Contrib Microbiol 2006 13 191 199 16627966
53. In vivo hybridisation of human tumour and normal hamster cells. Goldenberg DM, Pavia RA, Tsao MC, Nature 1974 250 649 651 10.1038/250649a0 4859359
54. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Teicher BA, Fricker SP, Clin Cancer Res 2010 16 2927 2931 10.1158/1078-0432.CCR-09-2329 20484021
55. Stem cell migration: a quintessential stepping stone to successful therapy. Weidt C, Niggemann B, Kasenda B, Drell TL, Zänker KS, Dittmar T, Curr Stem Cell Res Treat 2007 2 89 103 10.2174/157488807779317008 (Pubitemid 46723148)
56. Chemokine signaling in cancer: one hump or two? Rubin JB, Semin Cancer Biol 2009 19 116 122 10.1016/j.semcancer.2008.10.001 18992347
57. A novel function for chemokines: downregulation of neutrophil migration. Lang K, Hatt H, Niggemann B, Zaenker KS, Entschladen F, Scand J Immunol 2003 57 350 361 10.1046/j.1365-3083.2003.01247.x 12662298 (Pubitemid 36408206)
58. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Holland JD, Kochetkova M, Akekawatchai C, Dottore M, Lopez A, McColl SR, Cancer Res 2006 66 4117 4124 10.1158/0008-5472.CAN-05-1631 16618732
59. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ, Proc Natl Acad Sci USA 2001 98 2449 2454 10.1073/pnas.041604898 11226259 (Pubitemid 32209502)
60. A human breast epithelial cell type with stem cell characteristics as target cells for carcinogenesis. Chang CC, Sun W, Cruz A, Saitoh M, Tai MH, Trosko JE, Radiat Res 2001 155 201 207 10.1667/0033-7587(2001)155[0201:AHBECT]2. 0.CO;2 11121235 (Pubitemid 33723539)
61. The neurotransmitter gamma-aminobutyric-acid (GABA) is a potent inhibitor of the stromal cell-derived factor-1. Seidel J, Niggemann B, PunÖzel M, Fischer J, Zänker KS, Dittmar T, Stem Cells Dev 2007 16 827 836 10.1089/scd.2007.0004 17999603 (Pubitemid 350125222)
62. Differential effects of culture conditions on the migration pattern of stromal cell-derived factor-stimulated hematopoietic stem cells. Weidt C, Niggemann B, Hatzmann W, Zanker KS, Dittmar T, Stem Cells 2004 22 890 896 10.1634/stemcells.22-6-890 15536181 (Pubitemid 39507077)
63. A simplified method for Ca2+ flux measurement on isolated human B cells that uses flow cytometry. Gergely L, Cook L, Agnello V, Clin Diagn Lab Immunol 1997 4 70 74 9008284 (Pubitemid 27063704)